+44 (0) 20 3311 7700
Search our consultants’ directory
To book an appointment please call +44 (0)20 3311 7700 or email imperial.private.healthcare@nhs.net
Biography
Professor Jiao’s basic science work is focused on MicroRNAs, circulating tumour cells (CTCs) and liver regeneration. For the first time he described CTCs residing in organs local to pancreatic or colon cancers, and identified three mRNAs to differentiate benign from premalignant pancreatic cystic tumours. Furthermore, he has described a range of innovative surgical techniques performing a large number of laparoscopic liver and pancreatic resections including laparoscopic Whipple’s procedures. In liver surgery, he introduced radiofrequency assisted liver partition with portal vein ligation for staged liver resection (RALPP). In pancreatic surgery, he described longitudinal pancreaticojejunostomy following Whipple’s for pancreatic reconstruction, and laparoscopic Long’s sleeve pancreaticogastrostomy (LPG) for central pancreatectomy.
Professor Jiao has over 200 publications, including high IF journals as the first or senior author in Lancet Oncology, the Journal of Clinical Oncology, Gastroenterology and Annals of Surgery (publication link: http://www.ncbi.nlm.nih.gov/pubmed/?term=jiao+lr). His ambition is to improve the survival rates of pancreatic cancer.
Biography
Mr James Kinross is a senior lecturer in colorectal surgery and a consultant surgeon at Imperial College London. His clinical interest is in minimally invasive surgery for colorectal cancer and inflammatory bowel disease. He was trained in north west London, and he was an NIHR clinical lecturer in surgery and an Ethicon Laparoscopic Fellow in colorectal surgery.
He was awarded a Royal College of Surgeons of England training fellowship during his PhD and he was funded by the Academy of Medical Sciences as an early stage lecturer.
He is a visiting professor at the Royal College of Surgeons of Ireland.
Biography
Mr Jamie Murphy completed his medical school training at the University of St. Andrews, Harvard University and St. John’s College, Cambridge. After qualification he undertook his higher general surgical training at the Royal London Hospital and was awarded a PhD in colorectal molecular oncology.
Following this training he embarked upon three Colorectal Surgery fellowships at St. Mark’s Hospital to undertake specialist training in pelvic exenteration & sacrectomy for locally advanced/recurrent pelvic cancer, the Basingstoke Peritoneal Malignancy Institute for specialist training in the use of intraperitoneal chemotherapy for recurrent abdominal cancers and the Mayo Clinic in the USA for training in advanced minimally invasive surgery and the use of intraoperative radiotherapy to treat pelvic cancers that are unresectable. Following this subspecality training, Mr Murphy was appointed as assistant professor of surgery at Mayo Clinic prior to his return to London as a consultant colorectal surgeon at St. Mary’s and Hammersmith hospitals, London.
Mr Murphy’s specialist clinical and academic interests include the use of advanced minimally invasive surgery and the treatment of primary or recurrent abdominal/pelvic cancers. He has published and presented extensively and is a reviewer for numerous surgical journals.
Biography
Mr George Reese completed his MD thesis at Imperial College, London and progressed on to a surgical training rotation around central London teaching hospitals. He undertook the pan London fellowship in colorectal surgery before being appointed as an NHS consultant at Imperial College Healthcare NHS Trust. Mr Reese has a research interest in colonic imaging.
Biography
Mr Paul Ziprin qualified with an MBBCh in 1992 from the University of Wales College of Medicine. He was awarded an FRCS in 1996 and an FRCS (Gen Surg) in 2003. He completed a doctorate of medicine at the University of London in 2003.
Mr Ziprin was appointed as a consultant surgeon at Imperial College Healthcare NHS Trust in 2004. He is chair of the colorectal cancer multidisciplinary team and head of specialty in general surgery. He is part of the London Cancer Alliance Colorectal Pathway Group, the National Cancer Research Institute (NCRI) colorectal clinic studies group and from 2013 to 2016 the NCRI surgical subcommittee.